Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBT Margin (2016 - 2025)

Historic EBT Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 7.14%.

  • Nephros' EBT Margin rose 19400.0% to 7.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.53%, marking a year-over-year increase of 152000.0%. This contributed to the annual value of 0.63% for FY2024, which is 116900.0% up from last year.
  • Per Nephros' latest filing, its EBT Margin stood at 7.14% for Q3 2025, which was up 19400.0% from 5.57% recorded in Q2 2025.
  • Over the past 5 years, Nephros' EBT Margin peaked at 11.87% during Q1 2025, and registered a low of 71.98% during Q1 2022.
  • Over the past 5 years, Nephros' median EBT Margin value was 11.9% (recorded in 2023), while the average stood at 18.16%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -344000bps in 2022, then soared by 640000bps in 2023.
  • Over the past 5 years, Nephros' EBT Margin (Quarter) stood at 26.76% in 2021, then fell by -1bps to 26.94% in 2022, then grew by 29bps to 19.11% in 2023, then surged by 149bps to 9.41% in 2024, then fell by -24bps to 7.14% in 2025.
  • Its last three reported values are 7.14% in Q3 2025, 5.57% for Q2 2025, and 11.87% during Q1 2025.